TMELCY Trademark

Trademark Overview


On Wednesday, September 20, 2023, a trademark application was filed for TMELCY with the United States Patent and Trademark Office. The USPTO has given the TMELCY trademark a serial number of 79382511. The federal status of this trademark filing is REGISTERED as of Tuesday, July 16, 2024. This trademark is owned by IO Biotech ApS. The TMELCY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
tmelcy

General Information


Serial Number79382511
Word MarkTMELCY
Filing DateWednesday, September 20, 2023
Status700 - REGISTERED
Status DateTuesday, July 16, 2024
Registration Number7445425
Registration DateTuesday, July 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIO Biotech ApS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameIO Biotech ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameIO Biotech ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Monday, December 18, 2023ASSIGNED TO EXAMINER
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 10, 2023APPLICATION FILING RECEIPT MAILED
Monday, December 18, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 19, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 27, 2023REFUSAL PROCESSED BY MPU
Wednesday, December 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, January 14, 2024REFUSAL PROCESSED BY IB
Wednesday, January 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 5, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, February 5, 2024EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 5, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, March 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED